Skip to content

Search

Thinking big to tackle kids’ brain development

If there’s one thing modern researchers and health professionals now understand, it’s that for so many diseases and conditions affecting children and adolescents, early intervention is crucial.

UV offers new hope in fight against MS

People at risk of developing multiple sclerosis (MS) have been offered a beacon of hope thanks to research into UV exposure.

WA Aboriginal Child Health Survey preserved for future generations

The landmark Western Australian Aboriginal Child Health Survey has been placed into archiving at the State Library of Western Australia to be preserved for future generations.

Report: Pathways of young people in contact with multiple government agencies in Western Australia

Findings of a research study examining the characteristics of service use by a cohort of young people born between 1994-1997 who used four government services.

Australia-first mapping tool to improve service delivery to children and families launched

Data on Western Australian children’s health, learning, development and social characteristics will be mapped using geospatial technology so that community leaders and service providers can identify the priority issues for their children.

Charlotte loses locks to help cancer kids

You can make a difference to kids’ health at any age. Just ask 11-year-old Charlotte, who raised more than $11,000 for kids’ brain cancer research at The Kids Research Institute Australia simply by shaving her head.

Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia

Prevalence of skin sores and scabies in remote Australian Aboriginal communities remains unacceptably high, with Group A Streptococcus (GAS) the dominant pathogen. We aim to better understand the drivers of GAS transmission using mathematical models.

Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD)

The current prophylactic treatment to prevent rheumatic heart disease requires four-weekly intramuscular injection of a suspension of the poorly soluble benzathine salt form of penicillin G (BPG) often for more than 10 years. In seeking to reduce the frequency of administration to improve adherence, biodegradable polymer matrices have been investigated.

Rheumatic heart disease in Timor-Leste school students: an echocardiography-based prevalence study

The rates of RHD in Timor-Leste are among the highest in the world, and prevalence is higher among girls than boys. Community engagement is essential for ensuring follow-up and the effective delivery of secondary prophylaxis.